Status:
TERMINATED
Hospital In-Patient Insulin Study
Lead Sponsor:
The Royal Bournemouth Hospital
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduc...
Detailed Description
This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar ...
Eligibility Criteria
Inclusion
- Type II diabetes
- Blood glucose \> 17mmols
Exclusion
- Type I diabetes
- Hyperosmolar non-ketotic coma (HONK)
- Diabetic ketoacidosis (DKA)
- Myocardial infarction (MI)
- Vomiting
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00135070
Start Date
July 1 2005
End Date
June 1 2006
Last Update
May 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Bournemouth Hospital
Bournemouth, Dorset, United Kingdom, BH7 7DW